Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors Chemotherapy DNA BCL Inhibitors Epigenetics Immunotherapy MDM2/MDMX Other CD Protein Inhibitors Threonine-Tyrosine Kinase Inhibitors Proteasome Inhibitors FGF Chemokine Heat Shock Protein Inhibitors PI3 Kinase Inhibitors Cyclin Dependent Kinase Inhibitors Kinase Inhibitors PARP Inhibitors Cytokine | Acute Myelogenous Leukemia |
---|---|
midostaurin | |
venetoclax + azacitidine | |
midostaurin + gemtuzumab ozogamicin | |
decitabine | |
venetoclax | |
ponatinib | |
TP-0903 | |
PHI-101 | |
pexidartinib | |
quizartinib + RAIN-32 | |
venetoclax + quizartinib | |
HEC73543 | |
ARO-002 | |
gilteritinib + quizartinib | |
quizartinib | |
gilteritinib | |
venetoclax + gilteritinib | |
gemtuzumab ozogamicin | |
sorafenib | |
sorafenib + gilteritinib | |
venetoclax + ruxolitinib | |
FF-10101 | |
gilteritinib + PIN-A1 | |
cytarabine | |
selumetinib | |
gilteritinib + PRT811 | |
gilteritinib + DUP 785 | |
PLD-102 | |
midostaurin + 20D9-ADC | |
gilteritinib + SHP099 | |
PIN-A1 | |
SGN-CD33A | |
bortezomib + verteporfin | |
bortezomib | |
Max-40279 | |
ABBV-744 | |
venetoclax + SM09419 | |
venetoclax + IACS-010759 | |
midostaurin + SM09419 | |
dasatinib | |
CPI-0610 | |
olverembatinib + APG-115 | |
sorafenib + GMI-1359 | |
sorafenib | |
venetoclax + midostaurin | |
LAM 003 | |
ARO-002 + Wu-5 | |
gilteritinib + CUDC-907 | |
venetoclax + AMG 176 | |
quizartinib + PLX51107 | |
PLX51107 | |
SM09419 | |
quizartinib + LY2510924 | |
venetoclax + LAM 003 | |
palbociclib | |
SB939 + pacritinib | |
olaparib | |
venetoclax + ONO-7475 | |
quizartinib + Lys05 | |
quizartinib + IMGN779 | |
AIU2008 | |
DT-061 | |
olverembatinib + APG-2575 | |
gilteritinib + AMG 176 | |
quizartinib + STF-083010 | |
STF-083010 | |
quizartinib + PF-04691502 | |
TKI258 | |
quizartinib + AZD1208 | |
quizartinib + GMI-1359 | |
gilteritinib + AZD1208 | |
pelareorep | |
quizartinib + CC-90009 | |
ponatinib + SB-715992 | |
cabozantinib tablet | |
cabozantinib tablet + SB-715992 | |
CDDD11-8 | |
EC-70124 | |
TP-0184 | |
P22077 | |
venetoclax | |
DCAG | |
DA | |
FLT3 inhibitor + LIMK2 inhibitor | |
Bcl2 inhibitor + Tyrosine kinase inhibitor | |
FLT3 inhibitor + BET inhibitor | |
FLT3 inhibitor |